William M. Schneider

Rockefeller University — United States

Medicine · Health Sciences

26h-index8.8kcitations55works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(12), Hepatitis C virus research(9), interferon and immune responses(9), CRISPR and Genetic Engineering(8), SARS-CoV-2 and COVID-19 Research(7)

Publications55 total

An enhanced Eco1 retron editor enables precision genome engineering in human cells without double-strand breaks
Nucleic Acids Research·2025· 2 citedOpen Access
Hepatitis B Virus Nucleocapsid Assembly
Journal of Molecular Biology·2025· 6 citedOpen Access
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
Nature Reviews Gastroenterology & Hepatology·2025· 5 cited
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
PLoS Biology·2024· 12 citedOpen Access
An enhanced Eco1 retron editor enables precision genome engineering in human cells without double-strand breaks
2024· 2 citedOpen Access
Deep mutational scanning of hepatitis B virus reveals a mechanism for cis-preferential reverse transcription
Cell·2024· 8 citedOpen Access
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
2024· 1 citedOpen Access
An RNA-based system to study hepatitis B virus replication and evaluate antivirals
Science Advances·2023· 16 citedOpen Access
<scp>DDX60</scp> selectively reduces translation off viral type <scp>II</scp> internal ribosome entry sites
EMBO Reports·2022· 10 citedOpen Access
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
Cell Reports·2022· 30 citedOpen Access
Antiviral DExD/H-box helicase 60 selectively inhibits translation from type II internal ribosome entry sites
2022Open Access
Flavivirus–host interactions: an expanding network of proviral and antiviral factors
Current Opinion in Virology·2021· 18 citedOpen Access
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry
Viruses·2021· 18 citedOpen Access
Replication and single-cycle delivery of SARS-CoV-2 replicons
Science·2021· 81 citedOpen Access
Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms
Proceedings of the National Academy of Sciences·2021· 111 citedOpen Access
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
Cell Host & Microbe·2020· 168 citedOpen Access
TMEM41B Is a Pan-flavivirus Host Factor
Cell·2020· 195 citedOpen Access
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
Cell·2020· 429 citedOpen Access
Human hepatocyte PNPLA3 148M exacerbates rapid non-alcoholic steatohepatitis development in chimeric mice
2020· 2 citedOpen Access
TMEM41B is a pan-flavivirus host factor
2020· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Charles M. Rice(35), Eleftherios Michailidis(18), Hans-Heinrich Hoffmann(15), Margaret R. MacDonald(13), John T. Poirier(12), Ype P. de Jong(11), Inna Ricardo-Lax(10), Yingpu Yu(10), Jérémie Le Pen(9), Brandon S. Razooky(9), Joseph M. Luna(9), Xianfang Wu(9), Monica J. Roth(9), Alison W. Ashbrook(8), Ansgar F. Stenzel(8), Corrine Quirk(8), Francisco J. Sánchez‐Rivera(7), Avery Peace(7), Chenhui Zou(6), G.T. Montelione(6)